These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 25714010)

  • 21. MiR-128-3p suppresses breast cancer cellular progression via targeting LIMK1.
    Zhao J; Li D; Fang L
    Biomed Pharmacother; 2019 Jul; 115():108947. PubMed ID: 31078043
    [TBL] [Abstract][Full Text] [Related]  

  • 22. LIM kinase 1 increases tumor metastasis of human breast cancer cells via regulation of the urokinase-type plasminogen activator system.
    Bagheri-Yarmand R; Mazumdar A; Sahin AA; Kumar R
    Int J Cancer; 2006 Jun; 118(11):2703-10. PubMed ID: 16381000
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA-340 inhibits prostate cancer cell proliferation and metastasis by targeting the MDM2-p53 pathway.
    Huang K; Tang Y; He L; Dai Y
    Oncol Rep; 2016 Feb; 35(2):887-95. PubMed ID: 26718483
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Knockdown of p21-activated kinase 6 inhibits prostate cancer growth and enhances chemosensitivity to docetaxel.
    Wen X; Li X; Liao B; Liu Y; Wu J; Yuan X; Ouyang B; Sun Q; Gao X
    Urology; 2009 Jun; 73(6):1407-11. PubMed ID: 19362342
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Downregulation of Rac1/PAK1/LIMK1/cofilin signaling pathway in colon cancer SW620 cells treated with Chlorin e6 photodynamic therapy.
    Wufuer R; Ma HX; Luo MY; Xu KY; Kang L
    Photodiagnosis Photodyn Ther; 2021 Mar; 33():102143. PubMed ID: 33307230
    [TBL] [Abstract][Full Text] [Related]  

  • 26. LIMK1 promotes peritoneal metastasis of gastric cancer and is a therapeutic target.
    Kang X; Li W; Liu W; Liang H; Deng J; Wong CC; Zhao S; Kang W; To KF; Chiu PWY; Wang G; Yu J; Ng EKW
    Oncogene; 2021 May; 40(19):3422-3433. PubMed ID: 33883692
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Foxo3a-mediated overexpression of microRNA-622 suppresses tumor metastasis by repressing hypoxia-inducible factor-1α in ERK-responsive lung cancer.
    Cheng CW; Chen PM; Hsieh YH; Weng CC; Chang CW; Yao CC; Hu LY; Wu PE; Shen CY
    Oncotarget; 2015 Dec; 6(42):44222-38. PubMed ID: 26528854
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MiR-20a inhibits cutaneous squamous cell carcinoma metastasis and proliferation by directly targeting LIMK1.
    Zhou J; Liu R; Luo C; Zhou X; Xia K; Chen X; Zhou M; Zou Q; Cao P; Cao K
    Cancer Biol Ther; 2014 Oct; 15(10):1340-9. PubMed ID: 25019203
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A role for LIM kinase in cancer invasion.
    Yoshioka K; Foletta V; Bernard O; Itoh K
    Proc Natl Acad Sci U S A; 2003 Jun; 100(12):7247-52. PubMed ID: 12777619
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Upregulation of miR-93 and inhibition of LIMK1 improve ventricular remodeling and alleviate cardiac dysfunction in rats with chronic heart failure by inhibiting RhoA/ROCK signaling pathway activation.
    Su Q; Zhang P; Yu D; Wu Z; Li D; Shen F; Liao P; Yin G
    Aging (Albany NY); 2019 Sep; 11(18):7570-7586. PubMed ID: 31541994
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The pre-GAP-related domain of neurofibromin regulates cell migration through the LIM kinase/cofilin pathway.
    Starinsky-Elbaz S; Faigenbloom L; Friedman E; Stein R; Kloog Y
    Mol Cell Neurosci; 2009 Dec; 42(4):278-87. PubMed ID: 19666124
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Loss of EGFR signaling regulated miR-203 promotes prostate cancer bone metastasis and tyrosine kinase inhibitors resistance.
    Siu MK; Abou-Kheir W; Yin JJ; Chang YS; Barrett B; Suau F; Casey O; Chen WY; Fang L; Hynes P; Hsieh YY; Liu YN; Huang J; Kelly K
    Oncotarget; 2014 Jun; 5(11):3770-84. PubMed ID: 25004126
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined LIM kinase 1 and p21-Activated kinase 4 inhibitor treatment exhibits potent preclinical antitumor efficacy in breast cancer.
    Zhao CC; Zhan MN; Liu WT; Jiao Y; Zhang YY; Lei Y; Zhang TT; Zhang CJ; Du YY; Gu KS; Wei W
    Cancer Lett; 2020 Nov; 493():120-127. PubMed ID: 32829006
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA‑328 directly targets p21‑activated protein kinase 6 inhibiting prostate cancer proliferation and enhancing docetaxel sensitivity.
    Liu C; Zhang L; Huang Y; Lu K; Tao T; Chen S; Zhang X; Guan H; Chen M; Xu B
    Mol Med Rep; 2015 Nov; 12(5):7389-95. PubMed ID: 26459798
    [TBL] [Abstract][Full Text] [Related]  

  • 35. P21 activated kinase-1 (Pak1) promotes prostate tumor growth and microinvasion via inhibition of transforming growth factor β expression and enhanced matrix metalloproteinase 9 secretion.
    Goc A; Al-Azayzih A; Abdalla M; Al-Husein B; Kavuri S; Lee J; Moses K; Somanath PR
    J Biol Chem; 2013 Feb; 288(5):3025-35. PubMed ID: 23258534
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Downregulation of LIMK1-ADF/cofilin by DADS inhibits the migration and invasion of colon cancer.
    Su J; Zhou Y; Pan Z; Shi L; Yang J; Liao A; Liao Q; Su Q
    Sci Rep; 2017 Mar; 7():45624. PubMed ID: 28358024
    [TBL] [Abstract][Full Text] [Related]  

  • 37. p21-Activated kinase 6 (PAK6) inhibits prostate cancer growth via phosphorylation of androgen receptor and tumorigenic E3 ligase murine double minute-2 (Mdm2).
    Liu T; Li Y; Gu H; Zhu G; Li J; Cao L; Li F
    J Biol Chem; 2013 Feb; 288(5):3359-69. PubMed ID: 23132866
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LIM kinase 1 is required for insulin‑dependent cell growth of osteosarcoma cell lines.
    Zhang HS; Zhao JW; Wang H; Zhang HY; Ji QY; Meng LJ; Xing FJ; Yang ST; Wang Y
    Mol Med Rep; 2014 Jan; 9(1):103-8. PubMed ID: 24247826
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DGCR6L, a novel PAK4 interaction protein, regulates PAK4-mediated migration of human gastric cancer cell via LIMK1.
    Li X; Ke Q; Li Y; Liu F; Zhu G; Li F
    Int J Biochem Cell Biol; 2010 Jan; 42(1):70-9. PubMed ID: 19778628
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MiR-573 inhibits prostate cancer metastasis by regulating epithelial-mesenchymal transition.
    Wang L; Song G; Tan W; Qi M; Zhang L; Chan J; Yu J; Han J; Han B
    Oncotarget; 2015 Nov; 6(34):35978-90. PubMed ID: 26451614
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.